Facebook
Twitter
LinkedIn
ForwardEndovenous Thermal Ablation [CME] (CONG2014-30)
This course includes the following:
ETA: When is Concomitant Therapy Appropriate? Pro vs. Con
Kathleen Gibson, MD and Lowell Kabnick, MD, FACS, FACPh, RPhS
EHIT: Prevention, Identification and Management
Lowell Kabnick, MD, FACS, FACPh, RPhS
Safety of Thermal Ablation in the Patient on Anticoagulation
Kathleen Gibson, MD
Is ETA Effective in the Anticoagulated Patient?
Sherry Scovell-Fitch, MD
Update on Perforator Vein Treatment
Thomas O'Donnell, MD
Role of ETA and the Patient with Acute SVT: Pro vs. Con
Suman Rathbun, MD, MS, FACP, RVT and Sherry Scovell-Fitch, MD
ETA in the Hypercoagulable Patient: Pro vs. Con
Lowell Kabnick, MD, FACS, FACPh, RPhS and Marcus Stanbro, DO
Question and Answer
All Faculty
Steps to Successfully Complete This Activity
To participate in this educational activity please follow the steps listed below.
If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.
- To begin the activity click the START COURSE button.
- Progress through course content by using the NEXT button.
- Complete all required items in the course.
- Participants must score 80% or greater on the Post-Test to advance and receive credit. They are given three attempts to meet this threshold.
- Track your progress using the Course Progress menu.
- On the final page of the activity a link will be provided to download your certificate.
Target Audience
The content of this activity is designed to meet the needs of the following target audience: phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.
Learning Objectives
As a result of this activity the participant should be able to:
- Outline arguments for and against performing concomitant therapy in patients undergoing endothermal ablation.
- Define endothermal heat induced thrombosis and differentiate it from deep vein thrombosis.
- Describe the risks and benefits of continuing anticoagulation in patients undergoing endothermal ablation.
- Recognize the differences between normal, refluxing and pathologic perforator veins.
- Outline treatment protocols for patients with superficial thombophlebitis.
- Summarize arguments for and against the use of endothermal ablation in patients with hypercoaguable states.
| NAME | ROLE | COMMERCIAL INTEREST | TYPE OF RELATIONSHIP |
|---|---|---|---|
| Carl Black, MD | Content Reviewer | None | n/a |
| Yung-Wei Chi, DO, FAHA, FSVM | Planner | None | n/a |
| Kathleen Gibson, MD | Moderator; Speaker | BTG Sapheon Iverson Genetics Takeda Bayer AngioDynamics | Consultant; Principal Investigator Principal Investigator Principal Investigator Principal Investigator Principal Investigator Principal Investigator |
| Joseph T. Jenkins, MD, FACS, RPVI, RPhS, RVT | Content Reviewer | None | n/a |
| Lowell Kabnick, MD, FACS, FACPh, RPhS | Speaker | AngioDynamics Amsel Vascular Insights Veniti BTG | Consultant; Advisory Board; Speaker; Stockholder Consultant; Advisory Board; Stockholder Consultant; Advisory Board; Stockholder Stockholder Consultant |
| Stephen H. Moss | Staff | None | n/a |
| Diana L. Neuhardt, RVT, RPhS | Content Reviewer | BTG | Speaker |
| Thomas O'Donnell, MD | Speaker | Tactile Medical | Consultant |
| Suman Rathbun, MD, MS, FACP, RVT | Speaker | Diagnostica Stago BTG Inc. | Investigator Investigator |
| Sherry Scovell-Fitch, MD | Speaker | None | n/a |
| Cynthia K. Shortell, MD | Content Reviewer | None | n/a |
| Saundra Spruiell, DO, FACPh, RPVI | Planner | None | n/a |
| Marcus Stanbro, DO | Speaker | None | n/a |
| Sonja Stiller-Martin, MD | Content Reviewer | None | n/a |
| Mary Emily Wilcox Cummings, MD | Content Reviewer | None | n/a |
| Robert Worthington-Kirsch, MD, FSIR, FCIRSE, FACPh, RVT, RPVI | Content Reviewer | None | n/a |
Disclaimer
The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Discussion of Off-Label Use
Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Review & Recertification
This course was reviewed and recertified for AMA PRA Category 1 CreditTM in November 2016.
Available Credit
- 2.50 AMA PRA Category 1 Credit™
- 2.50 Attendance